<?xml version="1.0" encoding="UTF-8"?>
<p>It should also be noted that the FDA (Nonclinical Studies for the Safety Evaluation of Pharmaceutical Excipients) published a document that provides guidance on the development of safety profiles to support the use of new excipients as components of drugs or biological products, which could be applied in paediatric experiments [
 <xref rid="B14-pharmaceutics-13-00387" ref-type="bibr">14</xref>,
 <xref rid="B15-pharmaceutics-13-00387" ref-type="bibr">15</xref>].
</p>
